TOMOCUBE

25/09/2025

🌐 We’re excited to announce that Tomocube will be joining 𝗞𝗼𝗿𝗲𝗮 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗪𝗲𝗲𝗸 𝟮𝟬𝟮𝟱 — a global hub for innovation in 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗮𝗻𝗱 𝗥𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲!

📍 Seoul, Korea
📅 September 30 – October 1, 2025

We can’t wait to share our latest holotomography imaging technologies and connect with brilliant minds advancing science and medicine.💡

Even better — 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗷𝗼𝗶𝗻 𝘂𝘀 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘!
👉 Register here: https://www.lifescienceweek.com/kor/visitor/pre_regist.asp

Join us in Seoul to connect, collaborate, and inspire!

24/09/2025

📣 Tomocube is all set for 𝗠𝗜𝗖𝗖𝗔𝗜 𝟮𝟬𝟮𝟱 kicking off today!

Come visit us at Booth #07 from Sept 24–27 at Daejeon Convention Center and see how TomoAnalysis is shaping the future of digital pathology with AI-based Virtual Staining. Our software empowers researchers and pathologists to turn label-free images into meaningful insights.

💼 We’re also recruiting! Stop by to learn about exciting opportunities at Tomocube for graduate students and research professionals.

Discover how Tomocube is turning cutting-edge imaging concepts into real clinical impact—see you at Booth #07!

19/09/2025

We’re Hiring!

𝗕𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝗧𝗼𝗺𝗼𝗰𝘂𝗯𝗲’𝘀 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 to revolutionize 3D imaging.

We’re expanding our R&D and commercial teams worldwide and are looking for innovators in AI, software engineering, and life sciences to help push the boundaries of deep-tech biotechnology and precision metrology.

Join us on this journey of discovery and innovation as we continue shaping the future of science and technology.

👉 Explore exciting opportunities on our Career Page: https://tomocube.com/about_career

and Apply Now! 📩

18/09/2025

𝗖𝗢𝗠𝗣𝗔𝗖𝗧 𝗱𝗲𝘀𝗶𝗴𝗻 – 𝗨𝗡𝗖𝗢𝗠𝗣𝗥𝗢𝗠𝗜𝗦𝗘𝗗 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 – 𝗔𝗖𝗖𝗘𝗦𝗦𝗜𝗕𝗟𝗘 𝘁𝗼 𝗲𝘃𝗲𝗿𝘆 𝗹𝗮𝗯

🚀 HT-X1 mini – Tomocube's newest holotomography system, delivering high-resolution, label-free 3D imaging to every lab.

✨ Watch our X1 mini video and discover how this advanced imaging system can fit into your research: https://tomocube.com/products/htx1_mini

15/09/2025

⏰ Tonight’s the night!

𝗧𝗼𝗺𝗼𝗰𝘂𝗯𝗲 𝗧𝗲𝗰𝗵𝗗𝗮𝘆 𝗸𝗶𝗰𝗸𝘀 𝗼𝗳𝗳 𝗶𝗻 𝗷𝘂𝘀𝘁 𝟭 𝗵𝗼𝘂𝗿 at 10 PM (KST) / 3 PM (CET) / 9 AM (EDT).

Join us as we celebrate 10 years of growth and innovation with our CEO, Prof. YongKeun 'Paul' Park. From our evolving vision to the unveiling of an exciting new product, TechDay is your front-row seat to what’s next at Tomocube.

🌏 Wherever you are in the world, join the reveal and be part of this exciting event: https://www.youtube.com/watch?v=yxM8oPcLNOI

Welcome to Tomocube TechDay 2025.This year, we celebrate 10 years of innovation in holotomography, redefining the future of live-cell imaging and precision m...

12/09/2025

🚨 𝙉𝙖𝙩𝙪𝙧𝙚 𝘾𝙖𝙣𝙘𝙚𝙧 spotlight: ETH Zurich researchers uncovered that 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗲𝗹𝗹𝘀 𝗰𝗮𝗻 𝘁𝗿𝗮𝗻𝘀𝗳𝗲𝗿 𝘁𝗵𝗲𝗶𝗿 𝗺𝗶𝘁𝗼𝗰𝗵𝗼𝗻𝗱𝗿𝗶𝗮 𝘁𝗼 𝗳𝗶𝗯𝗿𝗼𝗯𝗹𝗮𝘀𝘁𝘀, reprogramming them into cancer-associated fibroblasts (CAFs) that drive tumor growth. This process depends on the mitochondrial trafficking protein MIRO2, making it a promising therapeutic target. The findings highlight a previously unknown way cancer cells reshape their microenvironment to their advantage.

🔬 To capture this hidden interaction, the team used holotomography, which enabled real-time, label-free visualization of mitochondria moving through tunneling nanotubes from cancer cells into fibroblasts. This direct evidence was critical in proving how mitochondrial transfer drives CAF differentiation.

Read the article: https://doi.org/10.1038/s43018-025-01038-6

10/09/2025

🥳 Tomocube’s newest holotomography product is launching soon!

And the big reveal will happen at 🚀𝗧𝗼𝗺𝗼𝗰𝘂𝗯𝗲 𝗧𝗲𝗰𝗵𝗗𝗮𝘆 on 𝗠𝗼𝗻𝗱𝗮𝘆, 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟭𝟱, 𝟭𝟬 𝗣𝗠 (𝗞𝗦𝗧).

Join us for this special 𝗼𝗻𝗹𝗶𝗻𝗲 𝗲𝘃𝗲𝗻𝘁 and be the first to see what’s next in 3D label-free imaging.

Register now, and we’ll send you an email reminder as the event approaches.
https://forms.office.com/r/6uay8zRGiM

05/09/2025

✨ New frontiers with holotomography ✨

A recent publication in 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 highlights how researchers are extending holotomography to new dimensions.

By adding polarization sensitivity, the study showed that 𝗵𝗼𝗹𝗼𝘁𝗼𝗺𝗼𝗴𝗿𝗮𝗽𝗵𝘆 𝗰𝗮𝗻 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲𝗹𝘆 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝘆 𝗹𝗶𝗽𝗶𝗱 𝗱𝗿𝗼𝗽𝗹𝗲𝘁𝘀 𝗶𝗻 𝗽𝗿𝗼𝘀𝘁𝗮𝘁𝗲 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗲𝗹𝗹𝘀, revealing their greater birefringence and accumulation under glucose treatment — key markers of altered cancer metabolism.

This study not only validates the label-free, quantitative strengths of holotomography but also showcases its potential as a platform for next-generation innovations in cancer metabolism research and diagnostics.

🔗https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202509420

At Tomocube, we are proud to see our technology enabling such world-class research, and we look forward to supporting the scientific community as they continue to push the boundaries of imaging.

03/09/2025

✨ Join us on Monday, 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟭𝟱, for a milestone event led by our CEO, Prof. YongKeun Park.

As Tomocube celebrates ten years of breakthroughs, this event sets the stage for the next chapter in our journey.

🔹 Discover our evolving vision for the future
🔹 Be the first to see our upcoming imaging system
🔹 Gain insights into our new division’s strategy and portfolio

Whether you’re a researcher, engineer, or our future partner, we invite you to join TechDay and be part of what’s next.

📅 Date: Monday, September 15
🕗 Format: Online event

Join our TechDay: https://forms.office.com/r/6uay8zRGiM

29/08/2025

This live-cell video showcases two remarkable cellular behaviors: 𝘁𝗵𝗲 𝗿𝗼𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗻𝘂𝗰𝗹𝗲𝘂𝘀 and active 𝗽𝗶𝗻𝗼𝗰𝘆𝘁𝗼𝘀𝗶𝘀, where the cell "drinks" its surrounding fluid by forming small vesicles.

Captured using high-resolution label-free imaging, the footage reveals the complex and dynamic nature of intracellular movement and nutrient uptake in real time.

Click to explore how is pushing the boundary of cell biology:
https://tomocube.com/application/cell_biology

27/08/2025

🧠✨ New insights into bipolar disorder metabolism

Congratulations to Prof. Jinju Han and colleagues at KAIST and collaborators on their recent publication in Molecular Psychiatry! The study revealed 𝗵𝗼𝘄 𝗮𝘀𝘁𝗿𝗼𝗰𝘆𝘁𝗲𝘀 𝗳𝗿𝗼𝗺 𝗯𝗶𝗽𝗼𝗹𝗮𝗿 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗲𝘅𝗵𝗶𝗯𝗶𝘁 𝗺𝗶𝘁𝗼𝗰𝗵𝗼𝗻𝗱𝗿𝗶𝗮𝗹 𝗱𝘆𝘀𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗮𝗯𝗻𝗼𝗿𝗺𝗮𝗹 𝗹𝗶𝗽𝗶𝗱 𝗱𝗿𝗼𝗽𝗹𝗲𝘁 𝗮𝗰𝗰𝘂𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻, with lithium correcting this only in responders.

To reveal these lipid droplet changes, researchers turned to Tomocube’s holotomography system, enabling 𝗹𝗮𝗯𝗲𝗹-𝗳𝗿𝗲𝗲, 𝟯𝗗 𝘃𝗶𝘀𝘂𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗾𝘂𝗮𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗹𝗶𝘃𝗲 𝗮𝘀𝘁𝗿𝗼𝗰𝘆𝘁𝗲𝘀. This approach solved a key challenge: tracking lipid metabolism without disrupting cell physiology.

🔍 The findings highlight astrocyte-specific metabolic dysfunction as a hallmark of bipolar disorder, and position lipid droplet imaging as a potential tool for new drug discovery.

Read the article here: https://www.nature.com/articles/s41380-025-03176-w

25/08/2025

📍 — A great start at 𝗞-𝗕𝗿𝗮𝗶𝗻 𝟮𝟬𝟮𝟱 & 𝘁𝗵𝗲 𝟯𝗿𝗱 𝗖𝗝𝗞 𝗡𝗲𝘂𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 with exciting discussions at our booth and inspiring poster presentations from our team!

We’re looking forward to more exciting discussions in the days ahead — come visit us if you’re here!